Chargement en cours...
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blo...
Enregistré dans:
| Publié dans: | J Pathol Transl Med |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253954/ https://ncbi.nlm.nih.gov/pubmed/32460474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2020.02.27 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|